These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6336916)

  • 1. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.
    Becker RE
    Am J Psychiatry; 1983 Feb; 140(2):208-11. PubMed ID: 6336916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants for depressed schizophrenic patients.
    Siris SG
    Am J Psychiatry; 1983 Dec; 140(12):1649-50. PubMed ID: 6359899
    [No Abstract]   [Full Text] [Related]  

  • 3. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
    Rickels K; Byrdy H; Valentine J; Postel W; Norstad N; Downing R
    Int Pharmacopsychiatry; 1978; 13(1):50-7. PubMed ID: 342437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of thiothixene with chlorpromazine in the treatment of mania.
    Janicak PG; Bresnahan DB; Sharma R; Davis JM; Comaty JE; Malinick C
    J Clin Psychopharmacol; 1988 Feb; 8(1):33-7. PubMed ID: 3280617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
    Ruiz-Navarro JF; Vergara L; Deutsch M
    Psychopharmacol Bull; 1976 Jan; 12(1):38-9. PubMed ID: 1108083
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Casey E
    Am J Psychiatry; 1988 Dec; 145(12):1532-7. PubMed ID: 3057924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive imipramine maintenance in post-psychotic depression/negative symptoms.
    Siris SG; Mason SE; Bermanzohn PC; Alvir JM; McCorry TA
    Psychopharmacol Bull; 1990; 26(1):91-4. PubMed ID: 2371372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory attention in process and reactive schizophrenia.
    Maloney MP; Sloane RB; Whipple K; Rzani J; Eaton EM
    Biol Psychiatry; 1976 Jun; 11(3):325-32. PubMed ID: 779856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
    Siris SG; Rifkin AE; Reardon GT
    J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group therapy and maintenance treatment of schizophrenics.
    Claghorn JL; Johnstone EE; Cook TH; Itschner L
    Arch Gen Psychiatry; 1974 Sep; 31(3):361-5. PubMed ID: 4606594
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
    Overall JE; Donachie ND; Faillace LA
    J Clin Psychiatry; 1987 Feb; 48(2):51-4. PubMed ID: 3542984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehesiven clinical studies with thiothixene.
    Ban TA; Lehmann HE; Sterlin C; Climan M
    Dis Nerv Syst; 1975 Sep; 36(9):473-7. PubMed ID: 240651
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment-resistant schizophrenia: controlled study of moderate- and high-dose thiothixene.
    Huang CC; Gerhardstein RP; Kim DY; Hollister L
    Int Clin Psychopharmacol; 1987 Jan; 2(1):69-75. PubMed ID: 3312398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
    Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
    Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial.
    Burnett GB; Little SR; Graham N; Forrest AD
    Dis Nerv Syst; 1975 Nov; 36(11):625-9. PubMed ID: 1102277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.